Prostate cancer represents the most encountered urinary malignancy in males over 50 years
old, and the second most diagnosed after lung cancer globally. Digital rectal examination …

Background A new generation of risk calculators (RCs) for prostate cancer (PCa)
incorporating magnetic resonance imaging (MRI) data have been introduced. However …

Abstract Purpose of Review Prostate cancer (PrCa) is the most common cancer in men in
the western world and is a major source of morbidity and mortality. Currently, general …

Abstract Background African American (AA) men have the highest incidence and mortality
rates of prostate cancer (PCa) among all racial groups in the United States. While race is a …

Objectives To assess of the clinical performance of Proclarix®(a novel Conformité
Européenne [CE]‐marked biomarker test aiding in the identification of clinically significant …

This review discusses evidence for population‐based screening with contemporary
screening tools. In Europe, prostate‐specific antigen (PSA)‐based screening led to a …

Purpose We aimed to develop and externally validate a nomogram based on MRI volumetric
parameters and clinical information for deciding when SBx should be performed in addition …

Over the past decade, compelling evidence has shown that multiparametric magnetic
resonance imaging (mpMRI) identifies International Society of Urological Pathology (ISUP) …

Purpose Unclear lesions on multiparametric magnetic resonance tomography (mpMRI) are
challenging for the indication of biopsy in patients with clinical suspicion of prostate cancer …

Simple Summary Magnetic resonance imaging (MRI)-associated prostate-specific antigen
density (mPSAD) and MRI predictive models have been proposed for improving the …